Vaccination Administration Errors Reported to the Vaccine Adverse Event Reporting System (VAERS) Elaine R. Miller, RN, MPH Beth Hibbs, RN, MPH Barbara.

Slides:



Advertisements
Similar presentations
The Vaccine Adverse Event Reporting System: A Tool for Safety and Surveillance Jane Woo, MD, MPH Vaccine Safety Branch Division of Epidemiology Office.
Advertisements

Provider Educational Resources 2009 North Carolina Immunization Conference August 13-14, 2009 Iyabode Akinsanya-Beysolow, M.D., M.P.H. Medical Officer,
Vaccines What is new ? Umayya M.Musharrafieh, MD American University of Beirut Medical Center November 10-12, 2006.
UIC College of Nursing Clinical Requirements Immunity Records CPR.
1 Cover page Let’s Review Changes in CDC Recommendations in 2011 Carolee’s Corner January 2012 MPCA
Importance of Vaccine Safety Decreases in disease risks and increased attention on vaccine risks Public confidence in vaccine safety is critical Low tolerance.
Julianne Gee, MPH Immunization Safety Office
Vaccine Administration
Coding for Childhood Immunizations Update for Pediatric Offices-
Implementing WA New State Exemption Requirements - Training for Schools and Child Cares/Preschools August XX, 2011 Preschool/Child Care Immunization Requirements.
Part II: Vaccine Administration. Objectives  Participants will gain knowledge and enhance skills of current immunization issues by: Identifying common.
Chapter 9: Parenteral Dosages
2011 North Carolina Immunization Conference August 2011 Iyabode Akinsanya-Beysolow, M.D., M.P.H. Medical Officer National Center for Immunization and Respiratory.
RPMS Immunization Package Training - Reports Version 8.5*1 Amy Groom, MPH IHS Immunization Program Manager.
Challenges:  Patient Age  Live virus or split virus  Preservative free or with preservative  Combo vaccine or individual vaccine  Route of administration.
FDA’s MedWatch Program Outreach to Healthcare Professionals and the Public n Managing the Risks of Medical Product Use.
Adult Immunization 2010 Herpes Zoster (Shingles) Segment This material is in the public domain This information is valid as of May 25, 2010.
Vaccine Safety Concerns  Past of vaccines  Now most parents have never seen a case of diphtheria, measles, or other once- common diseases.  They therefore.
What's New on the Child and Adolescent Immunization Schedules William L. Atkinson, MD, MPH National Center for Immunization and Respiratory Diseases William.
Vaccine Safety Epidemiology and Prevention of Vaccine- Preventable Diseases National Immunization Program Centers for Disease Control and Prevention Revised.
Jeff Neccuzi, Director Division of Immunization Services WV Bureau for Public Health.
1 1 Immunization Update 2011 Connecticut Immunization Teleconference April 19, 2011 William Atkinson, MD, MPH National Center for Immunization and Respiratory.
Adult Immunization 2010 Tetanus, Diphtheria and Pertussis Segment This material is in the public domain This information is valid as of May 25, 2010.
TM 2011 Immunization Recommendations H. Cody Meissner, M.D. Professor of Pediatrics Tufts University School of Medicine Boston Floating Hospital for Children.
Immunizations: 101 The Basics of Vaccine Administration
By Ruth Kavita Senior Pharmaceutical Technologist, KNH.
ADOLESCENT IMMUNIZATIONS
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 31 Health Supervision.
Responsibilities and Principles of Drug Administration
5th Annual Advocacy Project: ImmuneWise Section on Medical Students, Residents, and Fellowship Trainees
Medication Errors Prepared by: Abdullhadi Burzangy.
Administration Safety PHCL 492. Standards for Medicines Management  ‘When required to administer medication a practitioner is accountable for his or.
1 Vaccines and Related Biologic Products Advisory Committee (VRBPAC) May 16, 2007 FluMist ® Influenza Virus Vaccine Live, Intranasal Safety and Effectiveness.
1 Serious Adverse Events Following Falsely Elevated Glucose Measurements Resulting from Administration of an IGIV Product Containing Maltose BPAC Meeting,
2010 Immunization Update ChildAdult Updates Child Combination vaccines Polio Hepatitis A Re-vaccination with meningococcal HPVAdult HPV-2 types-males.
Administering Injections and Immunizations
Presentation Outline Introduction Reasons to Immunize Adults: Make the Case Myths vs. Facts Barriers to Adult Immunization The Ask Adult Immunization Resources.
Pertussis and Pertussis Vaccines Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory Diseases.
8 Medication Errors and Prevention.
Preventing Vaccine Errors in the Real World: Providing Better Protection to Prevent Vaccine Preventable Diseases Cindy Schulte, RN, BSN VPD Surveillance.
Progress in adolescent vaccination coverage levels in the United States National Immunization Conference Washington, DC March 31, 2011 Shannon Stokley,
1 Syncope and Related Injuries after Vaccination Wan-Ting Huang, MD Immunization Safety Office Office of the Chief Science Officer The 42 nd National Immunization.
National Immunization Conference March 30, 2011 Elaine R. Miller, RN, MPH Beth Hibbs, RN, MPH What Healthcare Providers Need to Know about the Vaccine.
1 Review of the Vaccine Adverse Event Reporting System (VAERS) Beth Hibbs RN, MPH; Elaine Miller RN, MPH Immunization Safety Office (ISO) Division of Healthcare.
Beth Hibbs, RN, MPH Immunization Safety Office - Division Of Healthcare Quality Promotion, Centers for Disease Control and Prevention Vaccination Errors.
Job Corps Webinar: Immunizations John Kulig MD MPH Lead Medical Specialist September 29 & 30, 2010.
Date of download: 6/22/2016 Copyright © 2016 McGraw-Hill Education. All rights reserved. Notes: aHepatitis B vaccine (HepB). AT BIRTH: All newborns should.
TM Influenza Vaccine Safety in Children: Data from VAERS John Iskander MD MPH Gina Mootrey DO MPH Penina Haber MPH Roseanne English-Bullard BS.
Using Surveillance Indicators for Vaccine-Preventable Diseases: National Notifiable Diseases Surveillance System Sandra W. Roush, MT, MPH National.
Welcome to the Immunization Requirements Webinar for Clinic Staff! For technical difficulties, call , press 1. During this webinar, everyone.
Review of VAERS reports involving seizures following 7-valent pneumococcal conjugate vaccine (PCV7) Scott Campbell, RN, MSPH* John Iskander, MD, MPH* Robert.
Vaccine Administration Fall 2009
Human Papillomavirus Kenneth McCall, BSPharm, PharmD, BCGP
Pertussis: New Vaccine, New Strategies
VFC Site Visit Questionnaire and AFIX as Tools for Quality Assessment
Immunization Update 2007 Tdap Vaccine Segment
ACIP Feb , 2007 Guillain-Barré Syndrome (GBS) Among Recipients of Meningococcal Conjugate Vaccine (MCV4,Menactra®) Update Oct Jan Robert.
Quadrivalent Human Papillomavirus Vaccine (HPV4) Adverse Events
What’s New in Adult Immunization
World Health Organization
Pediatric Inactivated Influenza Vaccine Safety VAERS Reports for Trivalent Inactivated Influenza Vaccine (TIV) in Infants/Toddlers Ann McMahon, MD, MS.
8 Medication Errors and Prevention.
World Health Organization
World Health Organization
Presentation transcript:

Vaccination Administration Errors Reported to the Vaccine Adverse Event Reporting System (VAERS) Elaine R. Miller, RN, MPH Beth Hibbs, RN, MPH Barbara Slade, MD CDC Immunization Safety Office

Background At least 8 new vaccines licensed since 2005 Increasing complexity of the immunization schedule Combination vaccines Institute of Medicine (IOM) report on medical errors in 2000 and medication errors in 2007 helped to raise awareness

CDC Publication on Vaccine Errors Confusion between Tetanus toxoid containing vaccines and tuberculin purified protein derivative (PPD) –March 2004, approximately 100 pts. in 21 states had received tetanus containing vaccines by the intradermal route instead of PPD –Similarities in packaging might have contributed to the medication errors. –Both products require refrigeration and often are stored side by side. *MMWR 2004; 53 (No.29)

Inadvertent Misadministration of Meningococcal Conjugate Vaccine –As of Aug. 2005, 101 people in 7 states were reported to have received the meningococcal conjugate vaccine (Menactra®) by the subcutaneous (SQ) route instead of the intramuscular route –The other meningococcal vaccine MPSV4 (Menomune®) which has been licensed for over 30 years, is given by the SQ route whereas Menactra® is licensed for IM route only. –CDC recommended that providers be aware of the licensed route of vaccines prior to administering them. *MMWR 2006; 55 (No.37) CDC Publication on Vaccine Errors-2005

CDC Publication with Information on Vaccine Errors (Page 27)* DTaP Tdap DTaP and Tdap Administration Errors May have occurred because of the similarity of names and appearance of packaging DTaP (pediatric) was mistakenly given to persons 7 years of age or older Tdap (adolescent/adult) was mistakenly given to children younger than 7 years *MMWR 2006; 55 (RR-3)

Study Objectives To analyze VAERS data to learn about trends and types of reported immunization errors during To use the data in order to develop a survey of health care providers about the causes of vaccine errors and how to prevent them.

Vaccine Adverse Event Reporting System (VAERS) National passive surveillance system for reporting adverse events after vaccination Co-managed by CDC and FDA Accepts reports from health care providers and the public VAERS strengths –Voluntary –Easy to report an adverse event –National in scope

Methods Search of the VAERS data from 1/1/06 to 9/30/07 for coding terms that indicated errors. Search terms used (MedDRA ® ): –ACCIDENTAL OVERDOSE –UNDERDOSE –DRUG ADMINISTERED AT INAPPROPRIATE SITE –DRUG ADMINISTRATION ERROR –DRUG DISPENSING ERROR –EXPIRED DRUG ADMINISTERED –INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION –INCORRECT ROUTE OF DRUG ADMINISTRATION –INCORRECT DRUG DOSAGE FORM ADMINISTERED –INCORRECT DOSE ADMINISTERED –MEDICATION ERROR –POOR QUALITY DRUG ADMINISTERED –WRONG DRUG ADMINISTERED –WRONG TECHNIQUE IN DRUG USAGE PROCESS All “SERIOUS” reports were reviewed (resulted in death, life threatening-illness, hospitalization, prolongation of existing hospitalization, permanent disability, or other medically important condition). Medical Dictionary for Regulatory Activities (MedDRA®)

Increase in VAERS Error Reports vs. All VAERS Reports over Time

Preliminary Results 1,895 reports submitted to VAERS between 1/1/06 and 9/30/07 contained a code indicating an error Of these 1,895 reports, 74 (3.9%) were classified as “serious” but the serious adverse events were not necessarily attributed to the medical error

Medication Error Reports Classified as “Serious” (1/1/06 – 9/30/07) 74 reports included a “serious” adverse event Of those 74, only 6 adverse events could be attributed to a medical error: 1.Pnemovax® given in intra-articular area in shoulder 2.Flu shot administered in intra-articular area in shoulder 3.When giving an HPV4 shot, the needle accidentally hit a bursa in the patient's arm requiring PT 4.Patient developed a sciatic neuropathy after an HPV4 shot 5.Disseminated varicella, status post varicella vaccination in an immunocompromised host (15 month old with langerhans cell histiocytosis who was recently on chemotherapy) 6.Eye injury to a nurse who inadvertently sprayed vaccine into her own eyes during vaccine preparation

Examples of Non-serious Reports Pt. was given 2 varicella doses at the same time. –MMRV in right arm along with a varicella vaccine in left arm,. Each vaccine was administered by a different medical assistant. Vials were retrieved from the refrigerator by a third medical assistant. Zostavax® was reconstituted with Gardasil® Rotateq® was given instead of Rocephin® Pt. with allergy to pertussis vaccine was given Tdap Reports of Rotateq being spit out into patient or providers eyes

Recommendations by Reporters Do not cut open boxes of vials until ready to administer Sometimes vials spill out of open boxes and are put in wrong box Separate similar vaccines in different areas of the refrigerator Post a chart to show which vaccines are given by the IM route and which are administered by the SubQ route Separate childhood vaccines from adult vaccines

Limitations VAERS data limitations: –Under reporting of medical errors to VAERS likely –Reports can be incomplete or inaccurate –Unknown denominator data e.g. number of doses administered –VAERS form is not designed for medical error surveillance Only “serious” reports were reviewed. Full data analysis in progress

Reporting Medication Errors Institute for Safe Medication Practices Accepts reports from consumers and health professionals related to medication. Publishes Safe Medicine, a consumer newsletter on medication errors U.S. Pharmacopeia MedMARX is an anonymous medication error reporting program used by hospitals VAERS The Vaccine Adverse Event Reporting System Accepts reports about adverse events following immunization MedWatch Accepts reports about products regulated by the FDA, including drugs and medical devices, through MedWatch, the FDA's safety information and adverse event reporting program

Resources for Preventing Vaccine Errors Immunization Action Coalition –DVD: Immunization Techniques "Safe, Effective, Caring” –Vaccine Storage and Handling Training Material Toolkit –Immunization Screening Questionnaire CDC –Vaccine Storage and Handling Toolkit 2008 –Immunization Practice Toolkit –Epidemiology and Prevention of Vaccine-Preventable Diseases: “the Pink book” Appendix C

“5 Rights of Medication Administration” 1) Right patient 2) Right time 3) Right dose 4) Right route 5) Right drug

Acknowledgments CDC VAERS team FDA VAERS team John Iskander Donna Weaver VAERS follow-up nurses: Margaret “Peggy” Clapp Sue Sargo Kathleen Reyes-Kelly